Progress within the adoption of clinical pathways, particularly in achieving standardization in cancer care, will be further discussed at Patient-Centered Oncology Care 2020®.
Progress within the adoption of clinical pathways, particularly in achieving standardization in cancer care will be further discussed at Patient-Centered Oncology Care 2020®, said Joseph Alvarnas, MD, of City of Hope and editor-in-chief of Evidence-Based Oncology™.
Transcript
AJMC®: This year’s Patient-Centered Oncology Care® 2020 will feature a panel to discuss progress in adoption of clinical pathways. What are the pressing issues in this area?
Dr Alvarnas: So, one of the dangers of lots of cancer care innovation is that all this technology, all this information, becomes used in haphazard ways. In ways that never allow us to create standardized models.
Without a degree of standardization, albeit standardization that respects the unique biology of the patient, we’ll never be able to deliver care in consistent ways, and consistency is very important. The other thing that's important is that how 1 center delivers care shouldn't radically differ from how another center delivers care, based upon things outside of science, knowledge, and what's testable.
I see pathways as a great way of achieving meaningful standardization that still respects the biological differentiation of patients affected by cancer. That's what's empowering about those kinds of pathways that are based upon emerging iterative knowledge. It allows us to achieve greater sustainability of care, and the ability for people, even those far, far in distance from an academic cancer center, to benefit from all the insights gleaned from the latest research or emerging clinical trials.
AJMC®: While COVID-19 is not specifically on the agenda, it’s never far from the discussion on cancer care delivery. What do you want to know from fellow participants about treating people with cancer during the pandemic?
Dr Alvarnas: COVID-19 has challenged far too much of our systems in society, and even society itself. We've struggled to figure out how to move forward, and unfortunately, an undue burden has been placed upon patients and families who are either beginning or in the midst of a cancer journey. Cancer patients constitute a particularly vulnerable population who are at greater risk from the perils and hazards of COVID-19.
What I'd like to learn is how our colleagues throughout the country have navigated this challenge, and set of challenges imposed by this, and how they've been able to transcend circumstances to ensure that patients continue to receive the care that they require, in a timely way that respects their needs.
New Insights on Breast Cancer Outcomes Among Sexual, Gender Minorities
December 7th 2023Despite there being a great demand for data collection on sexual orientation and gender identity in the cancer space, individuals who identify as a sexual and gender minority remain poorly represented.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Exagamglogene Autotemcel Meets End Points in Severe Sickle Cell Disease, β-Thalassemia
December 7th 2023Two posters set to be presented at the 65th American Society of Hematology Annual Meeting & Exposition met their primary and secondary end points regarding exagamglogene autotemcel therapy for sickle cell disease and β-thalassemia.
Read More
Reaching Rural America: Value-Based Care Solutions for Systemic Health and Social Inequalities
March 7th 2023On this episode of Managed Care Cast, we speak with Jennifer Schneider, MD, co-founder and chief executive officer of Homeward, a value-based care provider aiming to improve access to high-quality care in rural communities through tech-enabled clinical services, partnerships with local physicians and health plans, and community-level demographic data.
Listen
Race/Ethnicity May Influence Local Recurrence in DCIS, Adjuvant Treatment
December 6th 2023Disparities in 10-year local recurrence following breast-conserving surgery were seen among women with ductal carcinoma in situ (DCIS) treated over a nearly 4-decade span at Memorial Sloan Kettering Cancer Center, with Black women having the highest rate.
Read More
SDOH in Cancer Care Highlight Multifactorial Equity Issues
December 6th 2023A trio of speakers addressed the importance of social determinants of health (SDOH) in cancer care on day 1 of the 46th annual San Antonio Breast Cancer Symposium in the session, “Social Determinants of Health: Impact on Cancer Care.”
Read More